JSGAX Trails Russell 1000 Growth on Consumer, Health Picks

John Hancock U.S. Growth Fund (JSGAX) slightly underperformed the Russell 1000 Growth Index in the first quarter, the fund said in its Q1 2026 commentary. Stock selection in consumer discretionary and healthcare weighed on relative returns. Consumer discretionary and healthcare are among the largest sector weights in the growth index.

The fund did not name the specific holdings that lagged. The commentary described the underperformance as slight. The Russell 1000 Growth Index posted a gain during the quarter.

JSGAX is part of John Hancock's family of U.S. equity funds. The Q1 report is the fund's only scheduled public performance update for the period. The next commentary, covering Q2, will follow after the close of the quarter.